Bibliography

Found 57 results

Filters: Author is Letendre, S [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis RJ, Letendre S, Patrick C, Adame A, et al. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

B

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez RG, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458

C

Singh K, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):185-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579296

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR, Rosario-Cookson D, et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol Neurobiol. 2019 ;56(5):3808-3818.

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Langford D, Letendre S, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology (Zurich, Switzerland) [Internet]. 2003 ;13(2):195-210. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12744473

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693

Kaur H, Bush W, Letendre S, Ellis R, Heaton R, Patton S, J C, Samuels D, Hulgan T, Kallianpur A. CNS iron status is associated with neurocognitive function over time in HIV+ adults. 2017 .

Kaur H, Hulgan T, Fennema-Notestine C, Smieczek S, Letendre S, Ellis RJ, Bush WS, Soontornniyomkij V, Moore D, Masliah E, et al. Common SNPs in the HFE (hemochromatosis) gene are associated with neurocognitive impairment and aging-related neurodegenerative processes in HIV+ adults. 2017 .

Gonzalez RG, Heaton RK, Moore D, Letendre S, Ellis RJ, Wolfson TJ, Marcotte TD, Cherner M, Rippeth JD, Grant I, et al. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359

Marcotte TD, Deutsch R, Michael BDaniel, Franklin D, Cookson DRosario, Bharti AR, Grant I, Letendre S. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

D

Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan JA, Ellis RJ. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology [Internet]. 2005 ;169(1-2):144-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16182380

E

Langford D, Letendre S. Editorial commentary: Severe HIV-associated CD8+ T-cell encephalitis: is it the tip of the Iceberg?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America [Internet]. 2013 ;57:109-11. Available from: https://www.ncbi.nlm.nih.gov/m/pubmed/23515206/?i=1&from=/23515206/related

Letendre S, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte TD, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S72-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251831

Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre S, Grant I. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. Journal of Neurovirology [Internet]. 2007 ;13:150-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17505983

Letendre S, McCutchan JA, Childers ME, Woods SPaul, Lazzaretto D, Heaton RK, Grant I, Ellis RJ, HNRC. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology [Internet]. 2004 ;56:416-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15349869

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

F

Woods SPaul, Carey C, Moran LM, Dawson MS, Letendre S, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2007 ;22:187-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17289343

G

Pillai SK, Pond SLK, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain: A Journal of Neurology [Internet]. 2006 ;129:1872-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16735456

Pages